Moser Wealth Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Moser Wealth Advisors’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$7.02K	Sell	450 -1,800	-80%	-$25.1K	0.01%	109
2022 Q3	$29K	Hold	2,250	–	–	0.02%	95
2022 Q2	$32K	Hold	2,250	–	–	0.02%	97
2022 Q1	$32K	Hold	2,250	–	–	0.02%	98
2021 Q4	$31K	Hold	2,250	–	–	0.02%	101
2021 Q3	$37K	Sell	2,250 -400	-15%	-$6.71K	0.02%	98
2021 Q2	$45K	Hold	2,650	–	–	0.03%	97
2021 Q1	$48K	Hold	2,650	–	–	0.03%	92
2020 Q4	$48K	Hold	2,650	–	–	0.04%	88
2020 Q3	$47K	Buy	+2,650	New	+$48.3K	0.04%	84

Other funds holding TAK

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Moser Wealth Advisors's TAK Position: Q4 2022 in Review

Moser Wealth Advisors reduced its Takeda Pharmaceutical (TAK) stake by 80% in Q4 2022, selling an estimated $25.1K and leaving 450 shares worth $7.02K. The position accounts for 0.01% of the portfolio, ranked #109.

Moser Wealth Advisors first reported a position in TAK in Q3 2020 and has held it in 10 quarters since. The position peaked at $48K in Q1 2021. 281 funds tracked by Wall St. Rank hold TAK as of Q4 2022.

Moser Wealth Advisors held 450 shares of Takeda Pharmaceutical worth $7.02K as of Q4 2022.
Moser Wealth Advisors sold 1,800 Takeda Pharmaceutical shares in Q4 2022, an estimated $25.1K.
Takeda Pharmaceutical made up 0.01% of Moser Wealth Advisors's portfolio in Q4 2022, its #109 holding.
Moser Wealth Advisors first reported a position in Takeda Pharmaceutical in Q3 2020 and has held it in 10 quarters since.
Moser Wealth Advisors's Takeda Pharmaceutical position peaked at $48K in Q1 2021.
281 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2022.

Based on Moser Wealth Advisors's 13F filing for Q4 2022, filed 12 Jan 2023.